Farmers Trust Co. Has $5.37 Million Position in Solventum Co. (NYSE:SOLV)

Farmers Trust Co. lowered its holdings in Solventum Co. (NYSE:SOLV) by 0.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 81,334 shares of the company’s stock after selling 264 shares during the period. Farmers Trust Co.’s holdings in Solventum were worth $5,373,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in SOLV. Nuance Investments LLC acquired a new position in Solventum during the second quarter valued at approximately $115,829,000. Newport Trust Company LLC bought a new position in shares of Solventum in the 2nd quarter valued at $98,976,000. Baupost Group LLC MA acquired a new position in shares of Solventum during the 2nd quarter worth $96,242,000. Hotchkis & Wiley Capital Management LLC bought a new stake in shares of Solventum during the 3rd quarter worth $125,488,000. Finally, Trian Fund Management L.P. boosted its stake in Solventum by 32.9% in the third quarter. Trian Fund Management L.P. now owns 7,126,255 shares of the company’s stock valued at $496,842,000 after buying an additional 1,765,676 shares in the last quarter.

Analyst Upgrades and Downgrades

SOLV has been the topic of a number of research reports. Piper Sandler boosted their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Morgan Stanley boosted their price target on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a report on Monday, November 11th. Mizuho started coverage on shares of Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price objective for the company. Wolfe Research began coverage on shares of Solventum in a report on Thursday, September 26th. They set a “peer perform” rating on the stock. Finally, Stifel Nicolaus started coverage on shares of Solventum in a research note on Tuesday, October 8th. They set a “buy” rating and a $82.00 price target for the company. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $68.29.

Solventum Trading Down 0.6 %

SOLV traded down $0.45 during midday trading on Wednesday, reaching $68.96. 2,486,881 shares of the company were exchanged, compared to its average volume of 1,123,025. Solventum Co. has a one year low of $47.16 and a one year high of $96.05. The company’s fifty day moving average price is $69.59 and its 200 day moving average price is $64.63. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.